Ni Zhang

1.4k total citations
64 papers, 1.0k citations indexed

About

Ni Zhang is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ni Zhang has authored 64 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ni Zhang's work include Liver Disease Diagnosis and Treatment (6 papers), Nanoplatforms for cancer theranostics (5 papers) and COVID-19 and healthcare impacts (4 papers). Ni Zhang is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Nanoplatforms for cancer theranostics (5 papers) and COVID-19 and healthcare impacts (4 papers). Ni Zhang collaborates with scholars based in China, United States and Italy. Ni Zhang's co-authors include Lijun Xu, Xiangning Fu, Wei Xiang, Shu Peng, Ping Wei, Yangkai Li, Qi Wang, Lequn Li, Yunshu Su and Bo Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cell Metabolism.

In The Last Decade

Ni Zhang

60 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ni Zhang China 18 374 215 188 168 146 64 1.0k
Weida Wang China 20 485 1.3× 240 1.1× 240 1.3× 120 0.7× 112 0.8× 79 1.1k
Shijie Wang China 20 507 1.4× 264 1.2× 247 1.3× 163 1.0× 289 2.0× 104 1.4k
Jingqiang Zhu China 26 404 1.1× 266 1.2× 227 1.2× 83 0.5× 165 1.1× 140 2.3k
Daniel I. Bromage United Kingdom 18 416 1.1× 230 1.1× 74 0.4× 146 0.9× 94 0.6× 75 1.4k
Jie Ren China 18 474 1.3× 195 0.9× 235 1.3× 354 2.1× 128 0.9× 55 1.4k
Jiaxing Sun China 23 427 1.1× 172 0.8× 170 0.9× 173 1.0× 205 1.4× 92 1.4k
Yuan Gao China 21 348 0.9× 186 0.9× 124 0.7× 126 0.8× 204 1.4× 126 1.4k
Yanling Lv China 18 590 1.6× 189 0.9× 306 1.6× 74 0.4× 197 1.3× 62 1.2k
Xin Liao China 16 338 0.9× 134 0.6× 196 1.0× 183 1.1× 102 0.7× 68 873
Hang Li China 21 459 1.2× 485 2.3× 202 1.1× 87 0.5× 86 0.6× 71 1.3k

Countries citing papers authored by Ni Zhang

Since Specialization
Citations

This map shows the geographic impact of Ni Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Zhang more than expected).

Fields of papers citing papers by Ni Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Zhang. The network helps show where Ni Zhang may publish in the future.

Co-authorship network of co-authors of Ni Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Ni Zhang. A scholar is included among the top collaborators of Ni Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni Zhang. Ni Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Tang, Han, et al.. (2024). Biomimetic liposome amplifying mitochondrial damage to potential cancer radio-immunotherapy. Colloids and Surfaces B Biointerfaces. 242(36). 114091–114091. 3 indexed citations
4.
Zhang, Yafei, Ke Zhang, Bingyan Liu, et al.. (2024). Serum dithiothreitol-oxidizing capacity (DOC) is a promising biomarker for excluding significant liver fibrosis: a proof-of-concept study. BMC Medicine. 22(1). 278–278. 3 indexed citations
5.
Zhang, Xiang, Ming‐Hua Zheng, Dehua Liu, et al.. (2024). A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis. Cell Metabolism. 37(1). 59–68.e3. 19 indexed citations
6.
Zhang, Ni, et al.. (2024). Biomimetic Single‐Atom Nanozyme for Dual Starvation‐Enhanced Breast Cancer Immunotherapy. Advanced Healthcare Materials. 14(8). e2401362–e2401362. 31 indexed citations
7.
Liu, Wen‐Yue, Huai Zhang, Ni Zhang, et al.. (2023). A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia. The Journal of Clinical Endocrinology & Metabolism. 109(6). 1540–1549. 8 indexed citations
8.
Zhao, Jing, et al.. (2021). Achievement of long-term local control after radiation and anti-PD-1 immunotherapy in locally advanced non-small cell lung cancer. Therapeutic Advances in Chronic Disease. 12. 364095882–364095882. 1 indexed citations
9.
Wang, Qi, Yi Gao, Yixin Cai, et al.. (2020). Prevention and treatment of cross infection of novel coronavirus pneumonia in thoracic surgery ward. 371–375. 4 indexed citations
10.
Peng, Shu, Liu Huang, Bo Zhao, et al.. (2020). Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis. Journal of Thoracic and Cardiovascular Surgery. 160(2). 585–592.e2. 42 indexed citations
11.
Cai, Yixin, Yi Gao, Ping Wei, et al.. (2020). Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People’s Republic of China. Journal of Thoracic Oncology. 15(6). 1065–1072. 74 indexed citations
12.
13.
Song, Jiao, Liang Zhang, Hengjing Yi, et al.. (2019). NIR-responsive nanoplatform for pre/intraoperative image-guided carcinoma surgery and photothermal ablation of residual tumor tissue. Nanomedicine Nanotechnology Biology and Medicine. 20. 102020–102020. 18 indexed citations
14.
Leung, Elaine Lai Han, Zhong Qiu Liu, Vincent Kam Wai Wong, et al.. (2018). Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity. Cell Death and Disease. 9(2). 216–216. 42 indexed citations
15.
16.
Liu, Changyu & Ni Zhang. (2017). Diagnosis and treatment of esophageal tuberculosis. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 16(5). 533–535.
17.
18.
Liu, Zhengwen, et al.. (2008). Serum thrombospondin‐1 is altered in patients with hemorrhagic fever with renal syndrome. Journal of Medical Virology. 80(10). 1799–1803. 18 indexed citations
19.
Zhang, Ni. (2004). EFFECTS OF GLUCOSE CONCENTRATION AND pH ON H_2-PRODUCING CAPACITY WITH Clostridium R33 sp. nov.. 1 indexed citations
20.
Marcinkowski, Wojciech, et al.. (1997). Renal mRNA of PTH-PTHrP receptor, [Ca2+]i and phosphaturic response to PTH in phosphate depletion.. PubMed. 23(1). 48–57. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weida Wang Breakdown of academic impact, for papers by Shijie Wang Breakdown of academic impact, for papers by Jingqiang Zhu Breakdown of academic impact, for papers by Daniel I. Bromage Breakdown of academic impact, for papers by Jie Ren Breakdown of academic impact, for papers by Jiaxing Sun Breakdown of academic impact, for papers by Yuan Gao Breakdown of academic impact, for papers by Yanling Lv Breakdown of academic impact, for papers by Xin Liao Breakdown of academic impact, for papers by Hang Li
Rankless by CCL
2026